NVAX Stock Summary

• Equity multiplier, or assets relative to shareholders' equity, comes in at -1.13 for Novavax Inc; that's greater than it is for only 4.91% of US stocks.
• Revenue growth over the past 12 months for Novavax Inc comes in at -58.59%, a number that bests only 2.62% of the US stocks we're tracking.
• Novavax Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -61.91%, greater than the shareholder yield of just 5.31% of stocks in our set.
• Stocks that are quantitatively similar to NVAX, based on their financial statements, market capitalization, and price volatility, are ARDS, UMRX, ANAB, NKTR, and GRTS.
• NVAX's SEC filings can be seen here. And to visit Novavax Inc's official web site, go to www.novavax.com.